课题基金 / 基金详情

DRIVE TO SMOKE AND DOPAMINE BLOCKADE

DRIVE TO SMOKE AND DOPAMINE BLOCKADE
驾驶时吸烟和多巴胺阻断
批准号:
2654363
负责人:
Joseph Patrick McEvoy
金额:
$3.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-07-01 至 1997-11-30

项目摘要

项目成果

Joseph Patrick McEvoy的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Nicotine's enhancement of transmission in central dopaminergic pathways may be a primary reinforcing mechanism which drives smoking behavior. To explore this possibility we propose to study a group of individuals, i.e., patients with schizophrenia, who have a prevalence of smoking more than twice that of the general population. Certain symptoms of this disorder are believed due to dysfunction in dopamine pathways. Drugs to treat this disorder block dopamine receptors. We have developed reliable and valid measures of nicotine hunger, including cigarette self-administration sessions in which patients have repeated determinations of expired carbon monoxide during two hours of free access to cigarettes, and a smoke-mixing device which permits patients to select their preferred nicotine concentrations in cigarette smoke. We propose to measure nicotine hunger in 72 newly admitted patients with schizophrenia during a prospective neuroleptic-free washout, and on three subsequent occasions during a 42 day double-blind trial comparing three pharmacologically distinct dose levels of the dopamine receptor blocker, haloperidol. We will examine whether, and how, nicotine hunger changes in relation to haloperidol dose and plasma level, the unfolding of therapeutic response, and the development of extrapyramidal side effects. Two weeks into the double-blind haloperidol dose comparison, we will also determine the effects of four different dose levels of nicotine transdermal patch (O, 7, 14, or 21 mg, administered in a Latin square design balanced for order effects) on positive and negative psychopathology and extrapyramidal side effects. The proposed work will substantially clarify whether the excess of smoking in these patients reflects their efforts to treat their disease or to counteract the unwanted effects of its pharmacotherapy. It will also provide important information about the relationships between nicotine and dopamine systems which could not be obtained in other populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
7/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
  • 批准号:
    10442520
  • 项目类别:
  • 资助金额:
    $19.25万
  • 财政年份:
    2021
  • 负责人:
    Joseph Patrick McEvoy
  • 依托单位:
7/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
  • 批准号:
    10193994
  • 项目类别:
  • 资助金额:
    $19.25万
  • 财政年份:
    2021
  • 负责人:
    Joseph Patrick McEvoy
  • 依托单位:
7/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
  • 批准号:
    10655396
  • 项目类别:
  • 资助金额:
    $19.25万
  • 财政年份:
    2021
  • 负责人:
    Joseph Patrick McEvoy
  • 依托单位:
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
  • 批准号:
    8323934
  • 项目类别:
  • 资助金额:
    $32.33万
  • 财政年份:
    2009
  • 负责人:
    Joseph Patrick McEvoy
  • 依托单位:
国内基金
海外基金
DRD2/ERK/β-catenin信号联合Dopamine/ERK/TH调节环介导慢性应激促进脑胶质瘤恶性进展的研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    周秀萍
  • 依托单位:
11C-N-CH3-Dopamine PET/MRI心脏神经显像对射血分数保留的心衰的实验研究
  • 批准号:
    82171969
  • 项目类别:
    面上项目
  • 资助金额:
    56万元
  • 批准年份:
    2021
  • 负责人:
    王雪梅
  • 依托单位:
11C-N-CH3-Dopamine心肌Micro PET/CT显像对糖尿病心脏自主神经病变的评估
  • 批准号:
    82060323
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    34.0万元
  • 批准年份:
    2020
  • 负责人:
    何玉林
  • 依托单位:
11C-N-CH3-Dopamine神经显像对心肌"缺血记忆"的实验研究
  • 批准号:
    81460271
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    46.0万元
  • 批准年份:
    2014
  • 负责人:
    王雪梅
  • 依托单位: